|
|
Сonditions and diseases
AIDS/HIV ALS Alzheimer's Disease Anemia Anti-Aging Treatment Arterial Hypertension Autism Cancer Diabetes Treatment Eye Diseases Idiopathic Encephalopathy Ischemic Heart Disease Liver Diseases MD Treatment Multiple Sclerosis Treatment Parkinson Treatment Rheumatoid Arthritis SMA Ulcerative Colitis. Crohn’s Disease
News about stem cells
Stem cell treatment protects bone marrow from damaging chemotherapy effects in cancer patients
12 May
Stem cell therapy can protect cancer patients from damaging side-effects of chemotherapy, a new trial in the US suggests.
12 May
Stem cell therapy can protect cancer patients from damaging side-effects of chemotherapy, a new trial in the US suggests.
New Approach to Treating Muscular Dystrophy With Stem Cells
05 May
Scientists from the Lillehei Heart Institute (University of Minnesota) have developed a new efficient process of making muscle cells from human stem cells and for the first time ever effectively treated with these cells muscular dystrophy in a mice model.
05 May
Scientists from the Lillehei Heart Institute (University of Minnesota) have developed a new efficient process of making muscle cells from human stem cells and for the first time ever effectively treated with these cells muscular dystrophy in a mice model.
A New Brain Stem Cell Discovered
29 April
Adult brain contains stem cells, and Researchers at Lund University (Switzerland) found a new type of these cells.
All news
29 April
Adult brain contains stem cells, and Researchers at Lund University (Switzerland) found a new type of these cells.
Restoring vision with stem cells
According to The Los Angeles Times, a new stem cell method of restoring vision is to be tested by clinical trials in which embryonic stem cells will be transplanted into the retina. The U.S. Food and Drug Administration (FDA) granted permission for clinical trials to the study initiator, the Advanced Cell Technology (ACT), a biotechnology company.
The goal of the study is to evaluate the safety and effectiveness of the new method. In the trials, 12 elderly patients with dry form of age-macular degeneration will take part.
Age-related macular degeneration is a disease causing destruction of the macula (or yellow spot), the central part of the retina. Retinal pigment epithelium cells derived from human embryonic stem cells will be transplanted to the patients’ retina. Stem cell transplantation is expected to restore the cells damaged by the disease.
In the past, the trials presupposing stem cell transplantation into the retina were performed on rat models of age-related macular degeneration in whom they resulted in eyesight restoration. Apart from this, in November 2010, FDA granted the company the license for clinical trials of the new method of treating children’s Stargardt’s disease (hereditary macular degeneration) treatment.
The technology of stem cell line production developed by the company leaves embryos intact. Cell lines are derived from a single embryonic cell harvesting of which leaves embryo alive. Thus, according to the company, the new method is in line with ethical standards. Besides, similar manipulation is routinely performed during in vitro embryo genetic testing.
The goal of the study is to evaluate the safety and effectiveness of the new method. In the trials, 12 elderly patients with dry form of age-macular degeneration will take part.
Age-related macular degeneration is a disease causing destruction of the macula (or yellow spot), the central part of the retina. Retinal pigment epithelium cells derived from human embryonic stem cells will be transplanted to the patients’ retina. Stem cell transplantation is expected to restore the cells damaged by the disease.
In the past, the trials presupposing stem cell transplantation into the retina were performed on rat models of age-related macular degeneration in whom they resulted in eyesight restoration. Apart from this, in November 2010, FDA granted the company the license for clinical trials of the new method of treating children’s Stargardt’s disease (hereditary macular degeneration) treatment.
The technology of stem cell line production developed by the company leaves embryos intact. Cell lines are derived from a single embryonic cell harvesting of which leaves embryo alive. Thus, according to the company, the new method is in line with ethical standards. Besides, similar manipulation is routinely performed during in vitro embryo genetic testing.